GlassScriptPhysician profile
Alison Perkins Neff
NPI 1215145719
$1,647.35
in general payments reported to CMS, 2019-2025
22 companies · $849 in 2025
The $849 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.30 · 2020: $15.03 · 2021: $206 · 2022: $133 · 2023: $15.77 · 2024: $416 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,280.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $484.71 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $356.57 | 2021-2025 | Breztri, Airsupra |
| Corcept Therapeutics | $154.76 | 2024 | Korlym |
| Novo Nordisk INC | $109.04 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $49.28 | 2025 | Mounjaro, Zepbound |
| Therapeuticsmd, INC. | $46.28 | 2019-2022 | |
| Dexcom, INC. | $45.92 | 2025 | Dexcom G6 Transmitter |
| Amgen INC. | $44.12 | 2025 | Prolia, Evenity |
| Boston Scientific Corporation | $42.85 | 2022-2024 | Watchman Flx |
| Abbott Laboratories | $40.26 | 2022-2024 | Freestyle Libre 2 |
| Ironwood Pharmaceuticals, INC | $37.27 | 2022 | |
| Astellas Pharma US INC | $36.65 | 2025 | Veozah |
| Inspire Medical Systems, INC. | $33.89 | 2025 | Inspire |
| Lundbeck LLC | $23.33 | 2025 | Vyepti |
| Novartis Pharmaceuticals Corporation | $21.63 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $19.97 | 2024 | Evkeeza |
| Millicent US INC | $18.85 | 2025 | Femlyv |
| Merck Sharp & Dohme LLC | $18.66 | 2025 | Capvaxive, Gardasil 9 |
| Radius Health, INC. | $16.67 | 2025 | Tymlos |
| Bayer Healthcare Pharmaceuticals INC. | $15.82 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.60 | 2025 | Xifaxan |
| Esperion Therapeutics, INC. | $15.22 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Neff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.